Latest Breaking News On - Vedotin adcs - Page 1 : comparemela.com

Bradley Monk, MD, FACS, FACOG, discusses the rationale for investigating B7-H4–directed vedotin antibody-drug conjugates and highlights how these agents may address unmet needs for patients with gynecologic cancers.

Vedotin adcsCreighton university school of medicineCommunity research developmentHonorhealth research instituteUniversity of arizona college medicineDivision of gynecologic oncologyBradley monkGynecologic oncologyArizona collegeCreighton university schoolArizona oncologyUs oncology networkCreighton university school of medicine at st josephs hospitalUs oncology research networkThe gog foundationGog partners